AR069892A1 - Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion. - Google Patents
Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion.Info
- Publication number
- AR069892A1 AR069892A1 ARP080105645A AR069892A1 AR 069892 A1 AR069892 A1 AR 069892A1 AR P080105645 A ARP080105645 A AR P080105645A AR 069892 A1 AR069892 A1 AR 069892A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- free
- methods
- animal proteins
- protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 8
- 108090000623 proteins and genes Proteins 0.000 title abstract 8
- 235000018102 proteins Nutrition 0.000 abstract 7
- 102000004961 Furin Human genes 0.000 abstract 4
- 108090001126 Furin Proteins 0.000 abstract 4
- 235000021120 animal protein Nutrition 0.000 abstract 3
- 108010054218 Factor VIII Proteins 0.000 abstract 1
- 102000001690 Factor VIII Human genes 0.000 abstract 1
- 229960000301 factor viii Drugs 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108010047303 von Willebrand Factor Proteins 0.000 abstract 1
- 102100036537 von Willebrand factor Human genes 0.000 abstract 1
- 229960001134 von willebrand factor Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Furina recombinante (rFurina) y métodos para producir la rFurina. Más específicamente, rFurina libre de proteínas sustancialmente animal y métodos para producir la rFurina libre de proteínas sustancialmente animales. Reivindicacion 1: Una composicion caracterizada porque comprende furina recombinante libre de proteínas sustancialmente animal. Reivindicacion 2: La composicion de la reivindicacion 1 caracterizada porque comprende furina recombinante a una actividad de por lo menos alrededor de 10000 U de furina/ml y CHO proteínas de células huésped a una concentracion menos de alrededor de 11 mg proteína/ml. Reivindicacion 14: Un método de uso de la composicion de la reivindicacion 1 caracterizado porque comprende el paso de contactar a pro-proteína con la composicion en condiciones para disociar un pro-péptido de la pro-proteína para formar una proteína madura. Reivindicacion 15: El método de la reivindicacion 14 caracterizado porque la proteína madura es Factor de von Willebrand. Reivindicacion 16: El método de la reivindicacion 14 caracterizado porque la proteína madura es Factor VIII.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1815207P | 2007-12-31 | 2007-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069892A1 true AR069892A1 (es) | 2010-02-24 |
Family
ID=40524590
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080105645 AR069892A1 (es) | 2007-12-31 | 2008-12-19 | Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion. |
| ARP180103625A AR113492A2 (es) | 2007-12-31 | 2018-12-12 | Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180103625A AR113492A2 (es) | 2007-12-31 | 2018-12-12 | Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20090181423A1 (es) |
| EP (2) | EP3521422B1 (es) |
| JP (2) | JP5806465B2 (es) |
| KR (1) | KR101618144B1 (es) |
| CN (2) | CN101910401A (es) |
| AR (2) | AR069892A1 (es) |
| AU (1) | AU2008346817B2 (es) |
| BR (1) | BRPI0821467B8 (es) |
| CA (1) | CA2710260C (es) |
| DK (1) | DK2240578T3 (es) |
| ES (2) | ES2897561T3 (es) |
| HU (1) | HUE043863T2 (es) |
| MX (1) | MX2010007344A (es) |
| NZ (1) | NZ586411A (es) |
| PL (2) | PL3521422T3 (es) |
| PT (1) | PT2240578T (es) |
| SG (2) | SG10201805749QA (es) |
| WO (1) | WO2009088713A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5485873B2 (ja) * | 2007-05-22 | 2014-05-07 | バクスター・インターナショナル・インコーポレイテッド | ヒトフューリンのための予備的な精製方法 |
| WO2009088713A1 (en) | 2007-12-31 | 2009-07-16 | Baxter International Inc. | Substantially animal protein-free recombinant furin and methods for producing same |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| WO2012006594A1 (en) | 2010-07-08 | 2012-01-12 | Baxter International Inc. | Method of producing recombinant adamts13 in cell culture |
| US20140051832A1 (en) * | 2011-03-11 | 2014-02-20 | Universidade De São Paulo - Usp | Method for the production of recombinant human factor viii |
| SG195261A1 (en) * | 2011-06-02 | 2013-12-30 | Baxter Int | Formulations of recombinant furin |
| AR102048A1 (es) * | 2014-08-12 | 2017-02-01 | Baxalta Inc | Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina |
| MX383857B (es) * | 2014-12-22 | 2025-03-14 | Genzyme Corp | Métodos de cultivo de una célula de mamífero. |
| US11299533B2 (en) | 2017-06-23 | 2022-04-12 | Takeda Pharmaceutical Company Limited | Purification of factor VIII subspecies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1815207A (en) | 1929-01-18 | 1931-07-21 | John H Moffat | Vehicle parking and locking device |
| NL9000917A (nl) | 1989-10-25 | 1991-05-16 | Holland Biotechnology | Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. |
| DK0574402T3 (da) | 1990-11-26 | 1998-05-18 | Chiron Corp | Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf |
| US5604201A (en) * | 1993-01-08 | 1997-02-18 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Methods and reagents for inhibiting furin endoprotease |
| AT404838B (de) * | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
| WO1998015614A1 (en) | 1996-10-10 | 1998-04-16 | Life Technologies, Inc. | Animal cell culture media comprising plant-derived nutrients |
| AT407750B (de) | 1999-02-19 | 2001-05-25 | Immuno Ag | Verfahren zur herstellung einer vwf-präparation |
| US6596526B1 (en) * | 2000-06-09 | 2003-07-22 | Baxter Aktiengesellschaft | Furin polypeptides with improved characteristics |
| SE0103084D0 (sv) * | 2001-09-14 | 2001-09-14 | Amersham Pharm Biotech Ab | Generation of ion exchange media |
| US20030091976A1 (en) * | 2001-11-14 | 2003-05-15 | Ciphergen Biosystems, Inc. | Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| EP1520008B1 (en) * | 2002-07-09 | 2012-09-05 | Baxter International Inc. | Animal protein free media for cultivation of cells |
| US7750129B2 (en) * | 2004-02-27 | 2010-07-06 | Ge Healthcare Bio-Sciences Ab | Process for the purification of antibodies |
| PT1974014T (pt) * | 2006-01-04 | 2017-05-26 | Baxalta Inc | Meios de cultura celulares livres de oligopeptídeos |
| JP5485873B2 (ja) * | 2007-05-22 | 2014-05-07 | バクスター・インターナショナル・インコーポレイテッド | ヒトフューリンのための予備的な精製方法 |
| WO2009088713A1 (en) | 2007-12-31 | 2009-07-16 | Baxter International Inc. | Substantially animal protein-free recombinant furin and methods for producing same |
| US9718255B2 (en) | 2011-11-03 | 2017-08-01 | Barson Composites Corporation | Corrosion-resistant diffusion coatings |
-
2008
- 2008-12-19 WO PCT/US2008/087732 patent/WO2009088713A1/en not_active Ceased
- 2008-12-19 SG SG10201805749QA patent/SG10201805749QA/en unknown
- 2008-12-19 US US12/339,597 patent/US20090181423A1/en not_active Abandoned
- 2008-12-19 JP JP2010540818A patent/JP5806465B2/ja active Active
- 2008-12-19 MX MX2010007344A patent/MX2010007344A/es active IP Right Grant
- 2008-12-19 EP EP19163119.1A patent/EP3521422B1/en active Active
- 2008-12-19 DK DK08869658.8T patent/DK2240578T3/da active
- 2008-12-19 ES ES19163119T patent/ES2897561T3/es active Active
- 2008-12-19 CN CN2008801240838A patent/CN101910401A/zh active Pending
- 2008-12-19 PL PL19163119T patent/PL3521422T3/pl unknown
- 2008-12-19 HU HUE08869658A patent/HUE043863T2/hu unknown
- 2008-12-19 SG SG2013051693A patent/SG192471A1/en unknown
- 2008-12-19 EP EP08869658.8A patent/EP2240578B1/en active Active
- 2008-12-19 PL PL08869658T patent/PL2240578T3/pl unknown
- 2008-12-19 ES ES08869658T patent/ES2735173T3/es active Active
- 2008-12-19 PT PT08869658T patent/PT2240578T/pt unknown
- 2008-12-19 CA CA2710260A patent/CA2710260C/en active Active
- 2008-12-19 AU AU2008346817A patent/AU2008346817B2/en active Active
- 2008-12-19 NZ NZ586411A patent/NZ586411A/en unknown
- 2008-12-19 AR ARP080105645 patent/AR069892A1/es active IP Right Grant
- 2008-12-19 KR KR1020107017148A patent/KR101618144B1/ko active Active
- 2008-12-19 CN CN201811405688.6A patent/CN110066782B/zh active Active
- 2008-12-19 BR BRPI0821467A patent/BRPI0821467B8/pt active IP Right Grant
-
2010
- 2010-12-03 US US12/960,093 patent/US9127264B2/en active Active
-
2015
- 2015-06-03 JP JP2015112866A patent/JP2015154790A/ja not_active Withdrawn
-
2018
- 2018-12-12 AR ARP180103625A patent/AR113492A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR069892A1 (es) | Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion. | |
| AR043826A1 (es) | Formulaciones de proteinas y anticuerpos de alta concentracion | |
| KR900700116A (ko) | 뼈-유도 단백질 | |
| EA200001023A1 (ru) | Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью | |
| ATE272393T1 (de) | Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen | |
| CR8998A (es) | PRODUCCION DE TNFR-Ig Y FUSION DE PROTEINA | |
| ATE342962T1 (de) | Zusammensetzungen und verfahren für verbesserte zellkultur | |
| RU2010122052A (ru) | Рекомбинантный фактор viii, обладающий повышенной стабильностью | |
| AR063149A1 (es) | Formulaciones a base de polipeptidos estables | |
| NZ591292A (en) | Improved cell composition and methods of making the same | |
| CR8997A (es) | Produccion de polipeptidos | |
| NZ595495A (en) | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them | |
| MXPA03010433A (es) | Metodos para produccion recombinante de peptidos antifusogenicos. | |
| EP2536821A4 (en) | IMPROVING THE EFFECT OF FE-S-BUNDLE REQUIRING PROTEINS | |
| CO6231052A2 (es) | Polipeptidos de factor vii modificados y usos de los mismos | |
| DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| DE69939330D1 (de) | Wachstumsfaktor-homologe zvegf-3 | |
| Bab et al. | Isolation of mitogenically active C‐terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cells | |
| BRPI0514411B8 (pt) | formulação, e, método de produzir uma formulação | |
| AR012499A1 (es) | Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin | |
| Jankowski et al. | Defining ‘full‐length’recombinant factor VIII: a comparative structural analysis | |
| Collawn et al. | Conditioned media from adipose-derived stromal cells accelerates healing in 3-dimensional skin cultures | |
| ATE464320T1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| ES2192199T3 (es) | Ligandos de la familia eph biologicamente activos. | |
| TR200200048T2 (tr) | Otoproteolitik klevaj vasıtasıyla proteinlerin üretimi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |